Rate and predictors of biologic initiation in patients with severe asthma: a retrospective cohort study
Therapeutic Advances in Respiratory Disease · 2026-08 · 20
DOI: 10.1177/17534666261459926 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Therapeutic Advances in Respiratory Disease, online erschienen am 10.08.2026. Verfasst von John J Oppenheimer und 7 weiteren Autor:innen. Beteiligte Einrichtung: Pulmonary and Allergy Associates, Department of Internal Medicine, Rutgers New Jersey Medical School, 150 Bergen Street, Newark, NJ 07103, USA. Hauptthemen laut MEDLINE: Asthma, Anti-Asthmatic Agents, Biological Products. Die Arbeit nennt 84 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: GSK.
Abstract (Originalsprache)
Background
Biologic therapy uptake for poorly controlled severe asthma is suboptimal despite guideline recommendations.
Objectives
To evaluate real-world biologic initiation trends and predictors among patients with severe uncontrolled asthma (SUA) and SUA with eosinophilic phenotype (SUA-EP).
Design
A retrospective real-world cohort study that used Komodo Health administrative claims to identify US patients with SUA (controller/rescue medication use and ⩾2 asthma exacerbations in a year) and a subgroup of patients with SUA-EP (blood eosinophil count ⩾150 cells/µL in the year pre- or post-exacerbation).
Methods
Biologic initiation trends following first asthma exacerbation were assessed, and factors associated with lack of biologic initiation following second exacerbation (SUA-EP only) were identified using LASSO regression models; odds ratios (OR), 95% confidence intervals (CIs), and p -values were calculated using logistic regression.
Results
Biologic initiation rates following the first exacerbation were low at 12.7% (4360/34,246) and 12.2% (309/2526) of patients with SUA and SUA-EP, respectively; mean time between second exacerbation and initiation was 13.4 and 11.9 months. Predictors of lack of biologic initiation included young age (12–17 years; OR (95% CI) 3.65 (1.69–7.89)), primary care physician specialty at index relative to respiratory specialist (2.89 (2.04–4.10)), and antibiotic use (2.29 (1.44–3.66); all p < 0.05), indicating that younger patients, those managed by primary care and those treated with antibiotics for exacerbations, were less likely to receive biologics. Biologic initiation was more likely among patients with a cumulative systemic corticosteroid dose ⩾500 mg (prednisone equivalent; 0.38 (0.25–0.57)), those using leukotriene modifiers (0.42 (0.28–0.62)) or single-inhaler triple therapy (0.06 (0.01–0.40)), and those with eosinophilic disorders (0.19 (0.07–0.52); all p < 0.05).
Conclusion
Despite eligibility, most patients with SUA and SUA-EP did not receive any biologic; younger age and primary care management were predictors of lack of biologic initiation. This highlights the need for improved specialist referral and biologic uptake.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Pulmonary and Allergy Associates, Department of Internal Medicine, Rutgers New Jersey Medical School, 150 Bergen Street, Newark, NJ 07103, USA.
- GSK, Durham, NC, USA.
- Analysis Group, Montreal, QC, Canada.
- GSK, Upper Providence, PA, USA.
ORCID-Profile: John J Oppenheimer, Tom Corbridge
Förderung
- GSK
Zitieren
APA
Oppenheimer, J. J., Corbridge, T., Stach-Klysh, A., Germain, G., MacKnight, S. D., Boudreau, J., Laliberté, F., & Deb, A. (2026). Rate and predictors of biologic initiation in patients with severe asthma: a retrospective cohort study. Therapeutic Advances in Respiratory Disease, 20. https://doi.org/10.1177/17534666261459926
Vancouver
Oppenheimer JJ, Corbridge T, Stach-Klysh A, Germain G, MacKnight SD, Boudreau J, et al. Rate and predictors of biologic initiation in patients with severe asthma: a retrospective cohort study. Therapeutic Advances in Respiratory Disease. 2026;20. doi:10.1177/17534666261459926
BibTeX
@article{Oppenheimer2026,
author = {Oppenheimer, John J and Corbridge, Tom and Stach-Klysh, Alexandra and Germain, Guillaume and MacKnight, Sean D and Boudreau, Julien and Laliberté, François and Deb, Arijita},
title = {Rate and predictors of biologic initiation in patients with severe asthma: a retrospective cohort study},
journal = {Therapeutic Advances in Respiratory Disease},
year = {2026},
volume = {20},
doi = {10.1177/17534666261459926}
}
EUVIMED